A Case of Primary Malignant Melanoma of the Nasolacrimal Duct

Malignant melanoma of the nasal cavity and paranasal sinuses is an extremely rare disease, with only a few reported cases originating from or extending into the nasolacrimal duct. Multimodal treatments, including surgery, radiotherapy, chemotherapy, immunotherapy, and immune checkpoint inhibitors, have been attempted; however, the treatment outcomes remain unsatisfactory. We herein report a case of primary malignant melanoma of the nasolacrimal duct, which was successfully managed through complete en bloc resection of the nasolacrimal duct along with the surrounding bony structures, lacrimal sac, and puncta, followed by adjuvant radiotherapy and administration of immune checkpoint inhibitors. This multidisciplinary approach resulted in a favorable clinical course. Due to the rarity of mucosal malignant melanoma, many aspects of the disease remain unclear, and further evidence is warranted.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-04
DOI
https://doi.org/10.7759/cureus.98432
Citations
1
Primary Topic
Nasolacrimal Duct Obstruction Treatments
Type
article
Field-Weighted Citation Impact
1.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Primary Malignant Melanoma of the Nasolacrimal Duct

Takenori Ogawa, Mitsuhiro Matsumoto, Hisakazu Kato, Kosuke Terazawa et al.
1 citations
Cureus
Nasolacrimal Duct Obstruction Treatments
1.71
article

A Case of Primary Malignant Melanoma of the Nasolacrimal Duct

Takenori Ogawa, Mitsuhiro Matsumoto, Hisakazu Kato, Kosuke Terazawa, Ryo Utakata
article en
1 citations

Abstract

Malignant melanoma of the nasal cavity and paranasal sinuses is an extremely rare disease, with only a few reported cases originating from or extending into the nasolacrimal duct. Multimodal treatments, including surgery, radiotherapy, chemotherapy, immunotherapy, and immune checkpoint inhibitors, have been attempted; however, the treatment outcomes remain unsatisfactory. We herein report a case of primary malignant melanoma of the nasolacrimal duct, which was successfully managed through complete en bloc resection of the nasolacrimal duct along with the surrounding bony structures, lacrimal sac, and puncta, followed by adjuvant radiotherapy and administration of immune checkpoint inhibitors. This multidisciplinary approach resulted in a favorable clinical course. Due to the rarity of mucosal malignant melanoma, many aspects of the disease remain unclear, and further evidence is warranted.

CureusVol. 17(12)
Gifu University Hospital (JP), Gifu University (JP)
Openalex Percentile: Top 12%
Nasolacrimal Duct Obstruction Treatments
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.